Targazyme, Inc.

About Targazyme, Inc.

This author has not yet filled in any details.
So far Targazyme, Inc. has created 13 blog entries.

America Stem Cell, Inc. Awarded $2.5 Million from the Texas Emerging Technology Fund

SAN ANTONIO, TX, JULY 15, 2009 11:00 A.M. (CST). America Stem Cell, Inc. (ASC) www.americastemcell.com announced today that the company has been awarded $2.5 million from the State of Texas Emerging Technology Fund (“ETF”) www.emergingtechfund.com. This investment will enable ASC to accelerate the development of its breakthrough enzyme technology to enhance the homing and engraftment of cord blood stem cells, and achieve improved clinical outcomes for cancer patients receiving these stem cell transplants. ASC’s enzyme treatment could potentially transform cord blood stem cell engraftment, accelerate patients’ immune system and platelet recovery, reduce opportunistic infections and improve cord blood stem cell

By |July 15th, 2009|Categories: Press Releases|0 Comments